Role of Adipokines and Other Inflammatory Mediators in Gestational Diabetes Mellitus and Previous Gestational Diabetes Mellitus
Author(s) -
Nikolaos Vrachnis,
P. Belitsos,
Stavros Sifakis,
Konstantinos Dafopoulos,
Charalampos Siristatidis,
Kalliopi I. Pappa,
Zoi Iliodromiti
Publication year - 2012
Publication title -
international journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.875
H-Index - 60
eISSN - 1687-8345
pISSN - 1687-8337
DOI - 10.1155/2012/549748
Subject(s) - medicine , resistin , adipokine , adiponectin , gestational diabetes , leptin , diabetes mellitus , endocrinology , type 2 diabetes mellitus , retinol binding protein 4 , adipose tissue , insulin resistance , pathogenesis , metabolic syndrome , obesity , pregnancy , gestation , biology , genetics
Previous Gestational Diabetes Mellitus (pGDM) is a common condition and has been associated with future development of Type 2 Diabetes Mellitus (T2DM) and Metabolic Syndrome (MS) in women affected. The pathogenesis and risk factors implicated in the development of these conditions later in the lives of women with pGDM are not as yet fully understood. Research has recently focused on a group of substances produced mainly by adipose tissue called adipokines, this group including, among others, adiponectin, leptin, Retinol-Binding Protein-4 (RBP-4), and resistin. These substances as well as other inflammatory mediators (CRP, IL-6, PAI-1, TNF- α ) seem to play an important role in glucose tolerance and insulin sensitivity dysregulation in women with pGDM. We summarize the data available on the role of these molecules.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom